LONDON, UK – Media OutReach – 11 March 2019 – Vindobonum Finance B.V. (the “Issuer“) and Ceviz S?rt? Gayrimenkul Yat?r?mc?l??? ?n?aat Taahhüt Turizm A.?. as part of Capital Partners Ltd., and together with its fully consolidated subsidiaries (the “Group“), has mandated BMI International Europe Limited as Sole Placement Agent to arrange a series of fixed income investor meetings in Hong Kong, Singapore, Vienna, Zurich, Geneva and London, commencing on 12 March 2019.
The road show will start in Hong Kong on the 12th and Singapore on 14th, followed by the European part in Vienna on the 18th, in Zurich on 19th, Geneva on 20th, and finishing in London on 21st-22nd.
A proposed Regulation S only offering of Euro-denominated fixed rate guaranteed and secured notes (the “Notes“) of the Issuer may follow, subject to market conditions and investors’ interest.
MANUFACTURER TARGET MARKET (MIFID II PRODUCT GOVERNANCE) IS ELIGIBLE COUNTERPARTIES AND PROFESSIONAL CLIENTS ONLY (ALL DISTRIBUTION CHANNELS). NO PRIIPS KEY INFORMATION DOCUMENT (KID) HAS BEEN PREPARED AS NOT AVAILABLE TO RETAIL IN EEA.
No prospectus has been or will be approved and/or published pursuant to the Directive 2003/71/EC of the European Parliament and of the Council of 4 November 2003 on the prospectus to be published when securities are offered to the public or admitted to trading and amending Directive 2001/34/EC as amended (the “Prospectus Directive“). Neither this announcement nor any other announcement connected therewith may be distributed, passed on or disclosed to any other person in the European Economic Area, save as specifically agreed with BMI International Europe Limited. BMI International Europe Limited has represented and agreed that it will offer the Notes in the European Economic Area only in compliance with the provisions of the Prospectus Directive and all other laws and regulations in the European Economic Area applicable to the offer and the sale of the Notes in the European Economic Area.
NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR IN ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW
